DEXCOM INC
For the period ended Dec 31, 2024. Filed Feb 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 18, 2025
DXCM$79.92-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
DexCom, Inc.
Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| 2024 · 2023 · 2022 | |||
| (In millions) | |||
| Operating activities | |||
| Net income | $576.2 | $541.5 | $341.2 |
| Adjustments to reconcile net income to cash provided by operating activities: | |||
| Depreciation and amortization | 217.7 | 186.0 | 155.9 |
| Share-based compensation | 170.4 | 150.8 | 126.5 |
| Non-cash interest expense | 7.5 | 7.8 | 6.3 |
| Deferred income taxes | (43.8) | (55.0) | (21.6) |
| Other non-cash income and expenses | (47.3) | (85.8) | 34.5 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (35.0) | (260.1) | (199.9) |
| Inventory | 12.4 | (252.6) | 49.3 |
| Prepaid and other assets | (5.8) | 19.3 | (131.6) |
| Operating lease right-of-use assets and liabilities, net | (6.5) | (4.5) | (5.8) |
| Accounts payable and accrued liabilities | 211.7 | 466.5 | 295.1 |
| Accrued payroll and related expenses | (60.0) | 37.2 | 8.5 |
| Deferred revenue and other liabilities | (8.0) | (2.6) | 11.1 |
| Net cash provided by operating activities | 989.5 | 748.5 | 669.5 |
| Investing activities | |||
| Purchase of marketable securities | (2,576.3) | (3,200.4) | (2,266.3) |
| Proceeds from sale and maturity of marketable securities | 2,824.4 | 2,947.4 | 2,127.8 |
| Purchases of property and equipment | (358.8) | (236.6) | (364.8) |
| Acquisitions, net of cash acquired | — | — | (3.9) |
| Purchases of non-marketable equity securities | (81.3) | (19.5) | (14.5) |
| Other investing activities | (15.5) | 1.9 | 0.2 |
| Net cash used in investing activities | (207.5) | (507.2) | (521.5) |
| Financing activities | |||
| Net proceeds from issuance of common stock | 28.2 | 26.6 | 22.5 |
| Purchases of treasury stock | (750.0) | (688.7) | (557.7) |
| Proceeds from issuance of convertible notes, net of issuance costs | — | 1,230.6 | — |
| Purchases of capped call transactions | — | (101.3) | — |
| Payments for conversions of senior convertible notes | — | (787.3) | — |
| Other financing activities | (13.0) | 1.5 | (17.3) |
| Net cash used in financing activities | (734.8) | (318.6) | (552.5) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (7.4) | 1.5 | (5.8) |
| Increase (decrease) in cash, cash equivalents and restricted cash | 39.8 | (75.8) | (410.3) |
| Cash, cash equivalents and restricted cash, beginning of period | 567.5 | 643.3 | 1,053.6 |
| Cash, cash equivalents and restricted cash, end of period | $607.3 | $567.5 | $643.3 |
| Reconciliation of cash, cash equivalents and restricted cash, end of period: | |||
| Cash and cash equivalents | $606.1 | $566.3 | $642.3 |
| Restricted cash | 1.2 | 1.2 | 1.0 |
| Total cash, cash equivalents and restricted cash | $607.3 | $567.5 | $643.3 |
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Supplemental disclosure of non-cash investing and financing transactions: | |||
| Shares issued for repurchase and conversions of senior convertible notes | $— | $1,501.9 | $35.9 |
| Shares received under note hedge upon conversion of 2023 Notes | $— | $(1,490.3) | $(33.5) |
| Acquisition of property and equipment included in accounts payable and accrued liabilities | $75.4 | $53.2 | $25.7 |
| Supplemental cash flow information: | |||
| Cash paid during the year for interest | $11.4 | $12.4 | $12.2 |
| Cash paid during the year for income taxes | $198.0 | $212.3 | $114.2 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.